| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,958 |
8,706 |
$552K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,292 |
2,423 |
$96K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
608 |
551 |
$50K |
| 99439 |
|
549 |
540 |
$14K |
| T1015 |
Clinic visit/encounter, all-inclusive |
142 |
119 |
$12K |
| 99490 |
Ccm add 20min |
698 |
681 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
685 |
279 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
300 |
111 |
$5K |
| 99458 |
|
218 |
212 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
647 |
503 |
$4K |
| 99457 |
|
240 |
233 |
$3K |
| 82962 |
|
2,260 |
1,073 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
868 |
542 |
$2K |
| 96160 |
|
1,636 |
1,268 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
127 |
76 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,961 |
526 |
$933.96 |
| 96127 |
|
465 |
365 |
$793.45 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
125 |
65 |
$705.60 |
| 81025 |
|
140 |
86 |
$521.87 |
| 3077F |
|
1,135 |
790 |
$485.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
19 |
$455.18 |
| 3079F |
|
875 |
617 |
$425.00 |
| 3044F |
|
287 |
237 |
$410.00 |
| 90756 |
|
28 |
27 |
$339.10 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
31 |
26 |
$332.71 |
| 3074F |
|
653 |
496 |
$250.00 |
| 81003 |
|
208 |
131 |
$233.23 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
42 |
31 |
$212.58 |
| 3080F |
|
466 |
374 |
$185.00 |
| 3078F |
|
466 |
340 |
$175.00 |
| 3075F |
|
65 |
52 |
$25.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19 |
14 |
$3.15 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
318 |
243 |
$1.25 |
| 99454 |
|
120 |
114 |
$0.00 |
| 3008F |
|
8,632 |
5,960 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
21 |
14 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
174 |
69 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
9,423 |
6,578 |
$0.00 |
| 99453 |
|
42 |
42 |
$0.00 |
| 1160F |
|
22 |
18 |
$0.00 |